$0.5610
-0.02-4.12%
At close: -
$0.5800
0.023.39%
After Hours: Dec 20, 7:28 PM EDT
BriaCell Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BriaCell Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-12-16 | $-0.22 | $-0.30 | 26.7 % |
Sep 2024 | 2024-10-29 | $-0.07 | $-0.52 | 86.5 % |
Mar 2024 | 2024-06-14 | $0.11 | $-0.55 | 120.0 % |
Dec 2023 | 2024-03-18 | $-0.71 | $-0.20 | -255.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
BriaCell Therapeutics (BCTX) is scheduled to report earnings on March 17, 2025. The last reported earnings were for reported on December 16, 2024 for Q1.
The Actual EPS was $-0.22, which beat the estimate of $-0.30.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.